A significant discovery in cancer investigation is arising with the use of mini-antibodies to reactivate damaged p53. This crucial malignant inhibitor protein is frequently inactivated in many types of cancer, https://esocialmall.com/story7463285/mini-antibodies-reactivate-the-p53-protein-a-potential-hope-for-tumor-management